MJN-neuro

A social impact company to improve the quality of life for people with epilepsy and other diseases

OWNER

David Blánquez (See Profile)


Sector

Medical Device

Stage

Sales, licensing phases

Country

Spain


Medical device class IIa, CE mark for Europe and ISO 13485 for MJN, certified by BSI Group. USA FDA 510(k) in progress

Clinical trial to test algorithm performance, reached up to 95% sensitivity and a mean of 7 minutes before the seizure

Personalized artificial intelligence algorithms by recording users seizures and developed in an automated service

Commercialisation in Spain from December 2020, pre-agreement signed for UK and The Netherlands, Germany in progress

Patent PCT/ES2019/070659, WO 2020/070362 A1 approved, European and USA local phase initiated

IP Type Status Time Countries Link Coverage
PCT Approved 18 years
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • USA
  • United Kingdom
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020070362 A method for monitoring and assessing the risk of seizures for epilepsy users. Using a device in the ear canal and recording brain activity, EEG, using at least 1 sensor. Processing the data with an AI algortihm in segments of time and calculating the risk of suffering a seizure in the next minutes. The system is using at least 1 mathematical method to look for the pre-seizure moment to send a warning to the user.

IP Type Status Time Countries Link Coverage
Trademark Approved 5 years
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • USA
  • United Kingdom
https://www3.wipo.int/branddb/es/showData.jsp?ID=EMTM.017866730 MJN-SERAS
MARCA DE LA UNIÓN EUROPEA Nº17866730, “MJN-SERAS”
Clase 10, Boletín de Marcas de la Unión Europea 075/2018, correspondiente al 20 de Abril de 2018United States Patent and Trademark Office
Marca en USA n.º 87/909754, Reg. No. 5,791,807
Clase 10, publicada en Official Gazette correspondiente al 16 de Abril de 2019 y registrada 02 de Julio de 2019
Expires in 2028

IP Type Status Time Countries Link Coverage
Trade secret TD_014_001, protection of the algorithm that measures the risk of having an epilepsy seizure, using techniques of artificial intelligence, reading raw brain data, extracting meaningul statistical parameters and measurin the risk. Code, solution, model diagram and process
TD_014_002, protection of the cloud computing system, for the automatic generation of user-customized mathematical models of each user, which can later be integrated in mobile devices for real time seizure risk level measuring.Model diagram and process. Code, solution, model diagram and process.
TD_014_003, protection of CMake Compilation List, a tool that allows the compilation of the code independently of the used platform. It allows to compile the C++ code that will be run in Android devices, using Java or Kotlin language. Code, solution, model diagram and process.
TD_014_004, protection of EEG Data Formatting pipeline, a system to export raw data from EEG recorders and format it for cloud computing analysis, reading the exported data, indetifying the source and removing unwanted information. Code, solution, model diagram and process.

This information is confidential, do not share or copy.

Under evaluation at least till: 6th May

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar